Efficacy and Safety Oral Contraceptive Study

• Status: Completed
• Trial end date: 2006-01-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine whether the study drug is effective in prevention of pregnancy in healthy women in reproductive age

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Bayer
• Treatments: Contraceptive Agents; Contraceptives, Oral; Drospirenone

Criteria

Inclusion Criteria:

• Healthy woman requesting contraception

• Age between 18 and 35 years (inclusive), smokers maximum age of 30 years (inclusive)

Exclusion Criteria:

• Any conditions might interfere study outcome